Table 2.
Main characteristics of the 19 patients with blood, clinical and CMR data collected on the day of the 1st CMR, at a median of 3.2 months from the troponin peak.
| Age (years) | 66 [59–71] |
|---|---|
| Female | 2 (11%) |
| Diabetes | 7 (37%) |
| Dyslipidemia | 6 (32%) |
| Hypertension | 8 (42%) |
| Obesity (BMI > 30 kg/m2) | 7 (37%) |
| ARDS at acute phase | 16 (84%) |
| Peak troponin Ic at acute phase (ng/ml) | 242 [83–896] |
| Delay time from peak Troponin (months) | 3.2 [2.6–3.9] |
| Heart rate (bpm) | 80.0 [64.8–82.1] |
| Systolic BP (mmHg) | 134 [132–155] |
| Diastolic BP (mmHg) | 81 [72–85] |
| End-diastolic LV volume (mL/m2) | 63 [55–72] |
| LV ejection fraction (%) | 58 [52–65] |
| LV mass (g/m2) | 70 [59–80] |
| LV mass / volume ratio | 1.20 [0.91–1.27] |
| End-diastolic RV volume (mL/m2) | 56 [53–68] |
| RV ejection fraction (%) | 55 [51–59] |
| Myocardial T1 (ms) | 1,257 [1,221–1,270] |
| Myocardial T2 (ms) | 38.0 [36.0–40.2] |
| Myocardial ECV (%) | 27.6 [25.4–31.5] |
| Delayed retention myocarditis pattern | 2 (11%) |
| Skeletal T1 (ms) | 1,149 [1,110–1,149] |
| Skeletal ECV (%) | 16.5 [14.4–22.4] |
| Hematocrit (%) | 42.4 [40.3–43.9] |
| C Reactive Protein (mg/mL) | 4 (4) |
| Troponin Ic (ng/ml) | 6.0 [2.0–13.0] |
| Nt-pro BNP (pg/mL) | 111 [36–259] |
| Albumin (g/L) | 41.5 [39.1–46.4] |
| eGFR (ml/min/1.73 m2) | 90 [84–90] |
ARDS, acute respiratory distress syndrome; BNP, brain natriuretic peptide; BMI, body mass index; BP, blood pressure; ECV, extracellular volume; eGFR, glomerular filtration rate estimated with the CKD-EPI formula and truncated at 90 ml/min/1.73 m2; LV, left ventricle; RV, right ventricle; T1, longitudinal relaxation time; T2, transversal relaxation time.